SE384021B - Sett att framstella racemisk och optiskt aktiv 1-(2,5-diklorfenoxi)-3-tert.-butylamino-2-propanol och salter derav - Google Patents

Sett att framstella racemisk och optiskt aktiv 1-(2,5-diklorfenoxi)-3-tert.-butylamino-2-propanol och salter derav

Info

Publication number
SE384021B
SE384021B SE7203354A SE335472A SE384021B SE 384021 B SE384021 B SE 384021B SE 7203354 A SE7203354 A SE 7203354A SE 335472 A SE335472 A SE 335472A SE 384021 B SE384021 B SE 384021B
Authority
SE
Sweden
Prior art keywords
dichlorophenoxy
butylamino
racemic
propanol
tert
Prior art date
Application number
SE7203354A
Other languages
English (en)
Swedish (sv)
Inventor
A Hajos
M Fekete
M Kurti
S Elek
I Polgari
I Elekes
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of SE384021B publication Critical patent/SE384021B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
SE7203354A 1971-03-17 1972-03-15 Sett att framstella racemisk och optiskt aktiv 1-(2,5-diklorfenoxi)-3-tert.-butylamino-2-propanol och salter derav SE384021B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUGO001156 1971-03-17

Publications (1)

Publication Number Publication Date
SE384021B true SE384021B (sv) 1976-04-12

Family

ID=10996691

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7203354A SE384021B (sv) 1971-03-17 1972-03-15 Sett att framstella racemisk och optiskt aktiv 1-(2,5-diklorfenoxi)-3-tert.-butylamino-2-propanol och salter derav

Country Status (19)

Country Link
JP (1) JPS5310581B1 (xx)
AT (1) AT316515B (xx)
AU (1) AU461159B2 (xx)
BE (1) BE780719A (xx)
CA (1) CA1002537A (xx)
CH (1) CH569692A5 (xx)
CS (1) CS163270B2 (xx)
DK (1) DK133872B (xx)
ES (1) ES401235A1 (xx)
FI (1) FI55025C (xx)
FR (1) FR2130284B1 (xx)
GB (1) GB1337921A (xx)
IL (1) IL38870A (xx)
NL (1) NL170626C (xx)
NO (1) NO134836C (xx)
PL (1) PL88985B1 (xx)
SE (1) SE384021B (xx)
SU (1) SU496721A3 (xx)
YU (1) YU35435B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU172137B (hu) 1976-03-02 1978-06-28 Gyogyszerkutato Intezet Sposob poluchenija zamehhjonnykh proizvodnykh fenoksi-propanolamina

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1236523C2 (de) * 1962-02-15 1975-06-12 Sanol-Arzneimittel Dr. Schwarz Gmbh, 4019 Monheim Verfahren zur herstellung von basischen phenylaethern und deren salzen

Also Published As

Publication number Publication date
GB1337921A (en) 1973-11-21
ES401235A1 (es) 1975-02-16
SU496721A3 (ru) 1975-12-25
NL7203323A (xx) 1972-09-19
YU35435B (en) 1981-02-28
FI55025B (fi) 1979-01-31
DE2213044A1 (de) 1972-09-28
CA1002537A (en) 1976-12-28
FR2130284A1 (xx) 1972-11-03
NL170626B (nl) 1982-07-01
FR2130284B1 (xx) 1975-10-10
DE2213044B2 (de) 1977-05-26
BE780719A (fr) 1972-07-03
PL88985B1 (xx) 1976-10-30
AT316515B (de) 1974-07-10
FI55025C (fi) 1979-05-10
NL170626C (nl) 1982-12-01
IL38870A (en) 1975-08-31
JPS5310581B1 (xx) 1978-04-14
NO134836B (xx) 1976-09-13
NO134836C (xx) 1976-12-21
AU3965972A (en) 1973-09-13
CH569692A5 (xx) 1975-11-28
AU461159B2 (en) 1975-04-29
DK133872B (da) 1976-08-02
IL38870A0 (en) 1972-05-30
YU63972A (en) 1980-06-30
CS163270B2 (xx) 1975-08-29
DK133872C (xx) 1976-12-27

Similar Documents

Publication Publication Date Title
SE407799B (sv) Sett att framstella racemiska och optiskt aktiva 4-(polyalkoxifenyl)-2-pyrrolidoner anvendbara som nevropsykotropa lekemedel
YU63275A (en) Process for obtaining racemic and optically active 4-(polyalkoxy-phenyl)-2-pyrrolidones
SE435498B (sv) Forfarande for optisk isomer-uppdelning av racemisk 1,4-dimetoxi-6-hydroxi-6-acetyl-tetrahydronaftalen
SE409854B (sv) Sotningsmedel, 1-(2'-hydroxi-4'-karboximetoxi-fenyl)-3-(3-hydroxi-4-metoxi-fenyl)-propan-1-on och salter derav
NO149999C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme n-(4-acyloksyfenyl)-all-trans-retinamider.
ATA661577A (de) Verfahren zur herstellung von neuen, optisch akti-ven 3-azabicyclo(3.1.0)hexanderivaten und ihren nichttoxischen, pharmazeutisch vertraeglichen salzen
SU437290A3 (ru) Способ получения рацемических или оптически активных производных пиперазина
SE405970B (sv) Nytt sett att framstella 2-arylamino-2-imidazolin-derivat och salter derav
SE390171B (sv) Sett att framstella 7-(d-alfa-amino-alfa-fenylacetamido)-3-(s-(5-hydroaximetyl-1,3,4-oxadiazol-2-yl)tiometyl)-3-cefem-4-karbonsyra och icke toxiska, farmaceutiskt acceptabla salter derav
SE384021B (sv) Sett att framstella racemisk och optiskt aktiv 1-(2,5-diklorfenoxi)-3-tert.-butylamino-2-propanol och salter derav
SE414768B (sv) Forfarande for framstellning av alfa-aminobensylpenicilliner och salter derav
SE385123B (sv) Sett att framstella racemisk eller optiskt aktiv 13beta-etyl-17alfa-etynyl-gon-4-en-3-on-17beta-ol
SE387940B (sv) Forfarande for framstellning av stereoisomerer av 1-(1-(-kloorbensyl)-2'-pyrryl)-2-disek, butylaminoetanol
SU437289A1 (ru) Способ получени рацемических или оптически активных производных пиперазина
SE7508827L (sv) Forfarande och anordning for skakning av den ovre lopande parten i en planviramaskin.
SE401829B (sv) Forfarande for framstellning av 5-fenyl-6,7-bensomorfanderivat och salter derav
SE7507911L (sv) Sett att framstella nya nbeta-substituerade 8-beta-aminoetylergolin-i-derivat och deras salter.
SU558638A3 (ru) Способ получени соединений 1-фенокси-2-окси-3-аминопропана или их солей в виде рацемата или оптическиактивного антипода
SE384863B (sv) Forfarande for framstellning av 3,6-bis- (2-(1-azabicyklo(3,1,0)-hexan))-2,5-piperazindion
SE411672B (sv) Forfarande for framstellning av 1-(metylerad piperidino (och pyrrolidin-1-yl))-3-(substituerad fenoxi)-2-propanoler med terapeutisk verkan
SE7603779L (sv) Forfarande for framstellning av c-(2,6-dikloroanilino)fenylettiksyra och salter derav
SE7609719L (sv) Forfarande for framstellning av kvaternera salter
SE7613536L (sv) Sett att framstella 3,4-disubstituerade 2-(beta-naftyl-oxi)-etylpyrazoloner och anvendning derav som lekemedel
SE439010B (sv) Sett att framstella 1-bensoyl-2-(2',6'-diklorfenylamino)-2-imidazolin och salter derav
FI54409C (fi) Anordning foer uppvaermning av en vaetskesuspension med en annan vaetskesuspension